Michael Burshtine serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael Burshtine has executed 9 insider transactions totaling $3.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 4, 2008 involved exercising options for 32,665 shares valued at $202.2K.
Michael Burshtine currently holds 32,665 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Burshtine has been a net seller of OMRI stock. They have purchased $0 and sold $3.9M worth of shares.
Michael Burshtine's most recent insider trade was on Jan 4, 2008, when they sold 32,665 shares at $6.19 per share.
Get notified when new Form 4 filings are submitted
| $34.00 |
| Discretionary |
| Jan 3, 2008 | OMRI | $215.5K | Sale | 6,335 | $34.01 | Discretionary |
| Jan 3, 2008 | OMRI | $154.7K | Sale | 4,546 | $34.02 | Discretionary |
| Jan 3, 2008 | OMRI | $62.5K | Option Exercise | 4,546 | $13.75 | Discretionary |
| Jan 3, 2008 | OMRI | $39.2K | Option Exercise | 6,335 | $6.19 | Discretionary |
| Jan 2, 2008 | OMRI | $433.9K | Option Exercise | 70,091 | $6.19 | Discretionary |
| Jan 2, 2008 | OMRI | $2.4M | Sale | 70,091 | $34.45 | Discretionary |
| Jan 16, 2007 | OMRI | $0 | Award | 5,000 | $N/A | Discretionary |